Literature DB >> 19869150

STUDIES ON PNEUMOCOCCUS GROWTH INHIBITION : VI. THE SPECIFIC EFFECT OF PNEUMOCOCCUS SOLUBLE SUBSTANCE ON THE GROWTH OF PNEUMOCOCCI IN NORMAL SERUM-LEUCOCYTE MIXTURES.

R H Sia1.   

Abstract

By means of a method previously described for demonstrating the growth-inhibitory and pneumococcidal power of normal serum-leucocyte mixtures, a study was made to determine the action of pneumococcus soluble substance on the growth of strains of pneumococci avirulent for rabbits and cats. It was found that the presence of a very small amount of the purified soluble substance of the homologous type markedly altered the conditions in the mixture so that even a small number of avirulent pneumococci were enabled to grow in the serum and leucocytes of animals which possess the power to destroy ordinarily such pneumococci in relatively large numbers. The action of the soluble substance was shown to be highly specific to type. A Type II substance assisted the growth of only Pneumococcus Type II, likewise a Type III substance, the growth of Pneumococcus Type III only. Experiments involving broth filtrates of young pneumococcus cultures in place of the purified soluble substances gave similar results, thereby establishing further the identity of the purified substance with the precipitable substance originally described in the filtrates of pneumococcus cultures. The effect of the soluble specific substance of pneumococcus in the serum-leucocyte mixtures is, therefore, to confer on the avirulent pneumococcus of the homologous type the growth capacity of a virulent organism. The mechanism of the reaction is briefly discussed.

Entities:  

Year:  1926        PMID: 19869150      PMCID: PMC2131132          DOI: 10.1084/jem.43.5.633

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  5 in total

1.  THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS : SECOND PAPER.

Authors:  M Heidelberger; O T Avery
Journal:  J Exp Med       Date:  1924-08-31       Impact factor: 14.307

2.  THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS.

Authors:  M Heidelberger; O T Avery
Journal:  J Exp Med       Date:  1923-06-30       Impact factor: 14.307

3.  STUDIES ON PNEUMOCOCCUS GROWTH INHIBITION : II. A METHOD FOR DEMONSTRATING THE GROWTH-INHIBITORY AND BACTERICIDAL ACTION OF NORMAL SERUM-LEUCOCYTE MIXTURES.

Authors:  O H Robertson; R H Sia
Journal:  J Exp Med       Date:  1924-01-31       Impact factor: 14.307

4.  STUDIES ON PNEUMOCOCCUS GROWTH INHIBITION : V. THE RELATION OF VIRULENCE TO THE PNEUMOCOCCIDAL ACTIVITY OF NORMAL RABBIT SERUM-LEUCOCYTE MIXTURES.

Authors:  S T Woo
Journal:  J Exp Med       Date:  1926-04-30       Impact factor: 14.307

5.  THE ELABORATION OF SPECIFIC SOLUBLE SUBSTANCE BY PNEUMOCOCCUS DURING GROWTH.

Authors:  A R Dochez; O T Avery
Journal:  J Exp Med       Date:  1917-10-01       Impact factor: 14.307

  5 in total
  14 in total

1.  ON THE PRESENCE IN ANTIPNEUMOCOCCUS SERUM OF TYPE-SPECIFIC PROTECTIVE ANTIBODY NOT NEUTRALIZED BY HOMOLOGOUS SPECIFIC SOLUBLE SUBSTANCE.

Authors:  A B Sabin
Journal:  J Exp Med       Date:  1931-01-01       Impact factor: 14.307

2.  THE FATE OF ORALLY ADMINISTERED SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS TYPES I, II AND III.

Authors:  V Ross
Journal:  J Exp Med       Date:  1932-01-01       Impact factor: 14.307

3.  AN ANALYSIS OF THE OPSONIC AND TROPIC ACTION OF NORMAL AND IMMUNE SERA BASED ON EXPERIMENTS WITH THE PNEUMOCOCCUS.

Authors:  H K Ward; J F Enders
Journal:  J Exp Med       Date:  1933-03-31       Impact factor: 14.307

4.  STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMOCOCCAL PNEUMONIA : III. FACTORS INFLUENCING THE PHAGOCYTOSIS OF PNEUMOCOCCI IN THE LUNG DURING SULFONAMIDE THERAPY.

Authors:  W B Wood; C McLeod; E N Irons
Journal:  J Exp Med       Date:  1946-09-30       Impact factor: 14.307

5.  STUDIES ON PNEUMOCOCCUS GROWTH INHIBITION : VII. THE RELATION OF OPSONINS TO NATURAL RESISTANCE AGAINST PNEUMOCOCCUS INFECTION.

Authors:  O H Robertson; R H Sia
Journal:  J Exp Med       Date:  1927-07-31       Impact factor: 14.307

6.  AN EXAMINATION OF THE MECHANISM OF PNEUMOCOCCUS IMMUNITY BY MEANS OF BACTERICIDAL MEASUREMENTS : I. THE REACTION BETWEEN THE ANTICARBOHYDRATE ANTIBODY AND THE PURIFIED SPECIFIC CARBOHYDRATE.

Authors:  H K Ward
Journal:  J Exp Med       Date:  1932-03-31       Impact factor: 14.307

7.  THE RELATION BETWEEN ANTIANAPHYLAXIS AND ANTIBODY BALANCE : II. THE EFFECT OF SPECIFIC DESENSITIZATION UPON RESISTANCE TO INFECTION AND UPON ANTIBODY BALANCE.

Authors:  M C Morris
Journal:  J Exp Med       Date:  1936-09-30       Impact factor: 14.307

8.  STUDIES ON NATURAL IMMUNITY TO PNEUMOCOCCUS TYPE III : IV. OBSERVATIONS ON A NON-TYPE SPECIFIC HUMORAL FACTOR INVOLVED IN RESISTANCE TO PNEUMOCOCCUS TYPE III.

Authors:  J F Enders; C J Wu; M F Shaffer
Journal:  J Exp Med       Date:  1936-08-31       Impact factor: 14.307

9.  BACTERIOSTATIC EFFECT OF HUMAN SERA ON GROUP A STREPTOCOCCI : III. INTERFERENCE WITH BACTERIOSTATIC ACTIVITY BY BLOCKAGE OF THE LEUKOCYTES.

Authors:  S Rothbard
Journal:  J Exp Med       Date:  1945-08-01       Impact factor: 14.307

10.  CHANGES IN HUMORAL IMMUNITY OCCURRING DURING THE EARLY STAGES OF EXPERIMENTAL PNEUMOCOCCUS INFECTION.

Authors:  E E Terrell
Journal:  J Exp Med       Date:  1930-02-28       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.